Stryker Corporation has faced a challenging macro environment and is undergoing various supply shortages but this did not stop the company from delivering a solid growth in organic sales. While the company disappointed the Wall Street by failing to meet expectations in terms of both, revenues and earnings, its Neurotechnology and MedSurg net sales performance has been good. Spine and orthopedics net sales also increased in the quarter in constant currency. Inflation and negative foreign currency ....
06 Aug 2022
Stryker Corporation: The Vocera Acquisition & Other Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (08/22)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Stryker Corporation: The Vocera Acquisition & Other Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (08/22)
- Published:
06 Aug 2022 -
Author:
Ishan Majumdar -
Pages:
27
Stryker Corporation has faced a challenging macro environment and is undergoing various supply shortages but this did not stop the company from delivering a solid growth in organic sales. While the company disappointed the Wall Street by failing to meet expectations in terms of both, revenues and earnings, its Neurotechnology and MedSurg net sales performance has been good. Spine and orthopedics net sales also increased in the quarter in constant currency. Inflation and negative foreign currency ....